1. Volume 356, Issue 9241, Pages 1554-1559 (November 2000)
High-dose cyclophosphamide in severe aplastic anaemia: a randomised trial 
John F Tisdale, MD, Daniel E Dunn, MD, Nancy Geller, PhD, Michelle Plante, PharmD, Olga Nunez, BSN, Cynthia E Dunbar, MD, A John Barrett, MD, Thomas J Walsh, MD, Stephen J Rosenfeld, MD, Neal S Young, MD 
The Lancet 
Volume 356, Issue 9241, Pages (November 2000)
DOI: /S (00)
Copyright © 2000 Elsevier Ltd Terms and Conditions

2. Figure 1
Trial profile
The Lancet  , DOI: ( /S (00) )
Copyright © 2000 Elsevier Ltd Terms and Conditions

3. Figure 2
Kaplan-Meier estimates of proportion of patients reaching an absolute neutrophil count (ANC) of 0·50X109/L.
The Lancet  , DOI: ( /S (00) )
Copyright © 2000 Elsevier Ltd Terms and Conditions

4. Figure 3 Response proportions for evaluable patients at 3 and 6 months
Cy=cyclophosphamide; CR=complete response; PRi=partial response, transfusion-independent; PRd=partial response, transfusion-dependent.
The Lancet  , DOI: ( /S (00) )
Copyright © 2000 Elsevier Ltd Terms and Conditions